During the follow-up, the clinical outcomes were better in the PELD group, and the levels of C-reactive protein, creatine phosphokinase, and interleukin 6 were all lower in the PELD group than in the OD group. Here, IL6 is linked to severe neurodegenerative syndrome with lipodystrophy.